Heart failure & cardiomyopathies
Home CHF feasibility trial protocol: Impact of at-home Subcutaneous furosemide in patients with Chronic Kidney Disease and Heart Failure
Study context
- Population
- People with HF-CKD with at least one hospital admission within the preceding yearplanned recruitment (stage one), the first 80 to develop fluid accumulation to be randomised · Stage one - recruitment and monitoring 200 · Stage two - randomised 80
- Participants
- 200 people
- Planned comparison
- Usual care or at-home furosemide
- Primary endpoint
- recruitment and retention of participants, as well as adherence to the intervention
Methodological detailsrandomised controlled trial, protocol
- Randomised controlled trial
- Protocol
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Home CHF feasibility trial protocol: Impact of at-home Subcutaneous furosemide in patients with Chronic Kidney Disease and Heart Failure. ESC Heart Fail. Published 27 October 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →